+44 (0)1223 330484

Successes in global health action and justice: Insights from tackling HIV/AIDS and neglected diseases

Tuesday 9 May, 6.00 pm to 7.30 pm, Pavilion Rm

This is the third seminar in a series centred on Health Justice. Prof. Gregg Gonsalves, from Yale University, and Rachael Crockett and Dr. Wilfried Mutombo, from the Drugs for Neglected Diseases Initiative (DNDi), will talk about successes in global health action and justice.

Click here to sign up for the (free) event.

Gregg Gonsalves is an Associate Professor of Epidemiology at the Yale School of Public Health where he works on policy modeling for infectious diseases and substance use. Gregg worked as an activist and organiser for HIV/AIDS and other global health issues for 30 years prior to joining Yale, including advocating for access to AIDS treatment and essential medicines. Gregg will talk about his success in increasing access for HIV/AIDS as well as examples from his current work on policy modelling, including on the opioid and substance abuse epidemic in the US and mpox globally.

Drugs for Neglected Diseases Initiative (DNDi) is a not-for-profit research organization that develops new treatments against neglected tropical diseases. It was co-founded by the medical humanitarian Organization Médecins Sans Frontières (MSF) with a proportion of their Nobel Peace Prize award. Rachael Crockett and Dr. Wilfried Mutombo will talk about how DNDi develops new treatments for neglected patients, which are commonly underserved by pharmaceutical companies. They will also give examples of successes, including the development of the first oral treatment for sleeping sickness, and  discuss outstanding gaps that need tackling.

This FREE event is open for all and aimed at anyone with an interest in health justice. Non college members welcome.

To allow for networking/further discussion, a drinks reception will follow the formal part of the evening. So that we know how many to expect, please sign up using the Eventbrite link (where there will also be an option to request a zoom link if you cannot attend in person). Click here


  • Dr Neil J. Saad is a Visiting Fellow at Hughes Hall, University of Cambridge. He is an epidemiologist and an expert in humanitarian health and response to public health emergencies. He has worked for several years in humanitarian crises and conflict settings with Médecins Sans Frontières/Doctors Without Borders and the United Nations in the Democratic Republic of the Congo, Cambodia, Bangladesh, Syria, Jordan and the occupied Palestinian territory. He currently works at the World Health Organization in the Health Emergencies Programme, where he focusses on disease surveillance and outbreak response.


  • Gregg Gonsalves is an Associate Professor of Epidemiology at the Yale School of Public Health, an Associate (adjunct) Professor and research scholar at Yale Law School, and co-director of the Global Health Justice Partnership and the Collaboration for Research Integrity and Transparency. He received a B.S. (2011) and Ph.D. (2017) from Yale University. Prior to joining Yale, he worked as an activist and organiser for over 30 years on HIV/AIDS and other global health issues. He first worked as an activist with the AIDS Coalition to Unleash Power (ACT UP), cofounded the Treatment Action Group (TAG) and also worked with Gay Men’s Health Crisis and the AIDS and Rights Alliance for Southern Africa to improve access to essential medicines. He is a 2018 MacArthur Fellow and currently is a member of the World Health Organization’s mpox IHR Emergency Committee.
  • Rachael Crockett is a global health policy specialist with expertise working in strategic advocacy, research, equitable R&D, and policy. She is currently Policy Advocacy Manager at DNDi where she advocates for policy change to enable more effective and equitable R&D and access to the fruits of science for all people, no matter their income or where they live.
    Previously, she served as a civil society representative on the Therapeutics Pillar of ACT-Accelerator and was a member of the reference group for the ACT-A strategic review. During her time at Wellcome Trust she developed and led the organisation’s access to medicines policy programme which included authoring the SDG3 Global Action Plan for Healthy Lives and Well-Being for All accelerator on Research, Innovation and Access and has consulted for many multilateral and civil society organisations including WHO Science Division, WHO EURO and UNICEF.
  • Wilfried Mutombo is a medical doctor with a long experience on Human African Trypanosomiasis and clinical trial in remote and difficult environment. He is currently the “Head of Clinical Operations” at DNDi DRC Regional Office, he is coordinating all related clinical trial activities in DRC and in GuineaPreviously, he worked as general practitioner in a rural hospital and then he joined the HAT Control Program (PNLTHA). He oversaw HAT case management. Since 2006 , Dr Wilfried Mutombo is involved in clinical trial on HAT with DNDI. He was the Coordinating Investigator of “FEXINIDAZOLE”; the first oral drug for stage of HAT. He built a network of clinical site able to perform any clinical trial and currently , some of those sites are involved in both HAT and Filarial clinical trial.

Queries? contact Neil Saad (njs62)

Don’t miss …